NewsDesk @bactiman63 Prof Mojisola Christianah Adeyeye, Director-General National Agency for Food and Drug Administration And Control (NAFDAC) said the following yesterday in a press briefing: Background...

NewsDesk @bactiman63 The University of Oxford-developed and Serum Institute of India PvT Ltd (SIIPL)- manufactured and scaled up R21/Matrix-MTM malaria vaccine, leveraging Novavax’s adjuvant technology,...

NewsDesk @bactiman63 Malaria kills one child every 30 seconds, which approximates about 3000 children every day worldwide. Nearly 500,000 African children under the age of five die from this disease annually....

NewsDesk @bactiman63 A three-dose regimen of a whole-parasite vaccine against malaria – called Plasmodium falciparum sporozoite (PfSPZ) vaccine – demonstrated safety and efficacy when tested in adults...

NewsDesk @bactiman63 GSK announced today that the World Health Organization (WHO) has awarded prequalification to Mosquirix (also known as RTS,S/AS01), GSK’s groundbreaking malaria vaccine. This is...

By NewsDesk  @infectiousdiseasenews On Wednesday, the World Health Organization (WHO) announced their recommendation for widespread use of the RTS,S/AS01 (RTS,S) malaria vaccine among children in sub-Saharan...

By NewsDesk  @infectiousdiseasenews GSK, PATH, and Bharat Biotech (BBIL) Wednesday announced the signing of a product transfer agreement for the malaria vaccine, RTS,S/AS01E. The agreement includes the...

Here is a look at some interesting infectious disease and health news, opinion and research reported across the globe: Four dead from MERS virus in Oman Four people died in the Sultanate after being infected...

The World Health Organization Regional Office for Africa (WHO/AFRO) announced today that Ghana, Kenya, and Malawi will take part in a WHO-coordinated pilot implementation programme that will make the...

In a report published Wednesday in Nature, (Sterile protection against human malaria by chemoattenuated PfSPZ vaccine) investigators from the University of Tübingen reported all nine subjects (100%)...